Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 57Carcinoma, Non-Small-Cell Lung 29Breast Neoplasms 18Rectal Neoplasms 14Ovarian Neoplasms 14Carcinoma, Hepatocellular 10Neoplasm Metastasis 9Glioblastoma 9Colonic Neoplasms 9Carcinoma, Renal Cell 8Uterine Cervical Neoplasms 7Fallopian Tube Neoplasms 7Brain Neoplasms 6Neoplasms 5Nasopharyngeal Carcinoma 5Lung Neoplasms 5Triple Negative Breast Neoplasms 4Recurrence 4Liver Neoplasms 4Inflammatory Breast Neoplasms 4Colorectal Cancer Metastatic 4Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Pleural Effusion, Malignant 3Meningeal Carcinomatosis 3Melanoma 3Kidney Neoplasms 3Glioma 3Non-squamous Non-small Cell Lung Cancer 2Liver Metastasis Colon Cancer 2

Interventions

regorafenib 1Radiofrequency Ablation 1Nivolumab 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Cancer Liver Metastases × Bevacizumab × Clear all
NCT05588297 2022-10-20

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

Shanghai Changzheng Hospital

Phase 2 Unknown
12 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡